The American Society of Hematology supports free access to Blood on the broadest possible basis. Although ASH cannot adopt or support a publishing model that is not economically sustainable over the long run, certain sections of the journal are always publicly available online:
- Tables of contents
- Inside Blood Commentaries
- How I Treat articles
- Editor-in-Chief grants immediate free access to 5 clinical/research articles in each weekly issue (51 issues published annually)
Although we are unable to provide answers to specific and/or individual questions about hematological problems, conditions, diagnoses, or treatments, the American Society of Hematology, publisher of Blood, provides links to several third-party websites offering information on Blood diseases and related disorders. Please visit the Patient Resources section of the ASH website for further information.
Patients interested in obtaining a copy of an access-controlled article in Blood that may be helpful to their situation may do so by e-mailing a request to the Blood Publishing Office. The request should include the following information:
- Article citation information, including author(s), title of article, issue date & page number (example: Rafik Terra et al., T-cell generation by lymph node resident progenitor cells, July 1, 2005, p. 193). All citation information can be found with the article or abstract information online.
- Your name and email address
- Name of treating physician (optional)
Funded Research Options
The National Institutes of Health
ASH has developed an agreement with the National Institutes of Health (NIH) that provides an option to comply with the NIH policy on enhanced public access. Blood provides a service to all Blood authors who published NIH-funded articles, at no charge to the author, to deposit their paper to PubMed Central (PMC) on their behalf. This option, the PMC Archive Program, is the result of efforts by ASH and a group of nonprofit publishers to improve compliance with the current NIH public access policy while maintaining the publisher-mandated access embargoes. The program provides NIH with final articles representing NIH-funded research for an internal use archive at NIH. Authors must acknowledge explicitly in the text (i.e., Acknowledgement section of the article) of their research article that (a) the research in the article they authored was funded by NIH and (b) and/or their institutional affiliation with NIH in order for ASH to deliver the article to PMC shortly after final publication. PMC then will render the research article publicly available 12 months after final publication. This period of time is consistent with ASH’s publication embargo and ensures compliance with author copyright agreements with ASH.
Research Councils UK (RCUK) or Charity Open Access Fund (COAF) Funding
For articles whose author(s) are funded by RCUK (AHRC, BBSRC, ESPRC, ESRC, MRC, NERC, STFC) or COAF (Wellcome Trust, Arthritis Research UK, Breast Cancer Now, the British Heart Foundation, Cancer Research UK, Bloodwise, Parkinson’s UK), Blood deposits their article within 6 months of publication in an open repository, such as the Europe PubMed Central. Please note authors are also welcome to self-archive on institutional repositories, (see our Copyright policy for more information). To comply with the RCUK/COAF requirements, Blood requires a service fee of $1,000, as part of our standard publication fees. Authors will be charged only if their article is accepted, and they will be invoiced when they receive page proofs.
Italian Telethon Foundation
ASH has implemented a public access policy in which Italian Telethon Foundation-funded papers are deposited into PMC and are granted immediate and free access on the Blood website on payment of the $2,000 public access (Authors Choice) fee, in addition to the regular publication fees charged to authors. To further ensure author compliance with the Italian Telethon Foundation's open-access policy, special licensing language has been drafted to allow end-users of Italian Telethon-funded articles unrestricted access to these articles. Authors must acknowledge explicitly in the text (i.e., Acknowledgement section of the article) of their research article that (a) the research in the article they authored was funded by Italian Telethon Foundation (b) and/or their institutional affiliation with Italian Telethon Foundation in order for ASH to deliver your article to PMC shortly after final publication. Authors can find out more information about funded research access options for Blood during the manuscript submission process.
ASH Author Choice
ASH has extended its public access option to any author who would like their article to be immediate and freely available at publication. Upon payment of the $2,500 public access fee, in addition to the regular publication fees charged to authors, ASH will deposit the final, published version of the article into PMC and ensure free and immediate access to the article on the Blood website. Authors can find out more information about the public-access policy for Blood during the manuscript submission process.
Blood Online Legacy Content
Blood’s complete catolog of legacy content is archived online beginning with the first Blood issue in 1946. All Blood articles are publically available and freely accessible to everyone 12 months after publication. If authors choose, they can pay for free and immediate access (ASH Author Choice).
Non-subscribers may choose to access an individual article by using Blood’s pay-per-view option. Pay-per-view options will appear when looking at article or abstract information.
For information on ordering single print issues of Blood click here.